Omnisystem acquired 2,392,467 common shares worth approximately 2 billion KRW from June 16 to July 15, 2026, raising its treasury stock ratio to 4.03%.
The buyback was executed close to the planned amount of 2 billion KRW, but fewer shares were purchased due to a rise in stock price.
During the same period, the major shareholder Biosmart purchased approximately 2.13 million additional shares, increasing its stake.
[AI Summary]The treasury stock acquisition signals an intent to support the stock price and enhance shareholder value, but the lack of cancellation may limit its long-term impact. The major shareholder's concurrent buying adds credibility, but the future use of the repurchased shares requires further disclosure.